Healthcare
Rising diabetes cases propel medical devices market toward 8.1% CAGR through 2034
Rising diabetes cases propel medical devices market toward 8.1% CAGR through 2034
The industry is projected to reach $67.39b by end-period.
2 hours ago
IHH Healthcare bets on Fortis stake for Indian expansion
It plans to add 2,000 hospital beds by 2028.
5 hours ago
Singapore's Health ministry grants $78.9m in first tranche of community care pay rise
Salary guidelines provided at least a 7% increase.
1 day ago
AI in precision medicine market to soar to $38.9B by 2034 on 35.5% CAGR
Market growth is driven by ML, deep learning, EHR.
1 day ago
Ping An Good Doctor projected to see 56% profit CAGR surge by 2027
Ali Health adjusted net profit forecast at 24% CAGR.
1 day ago
Neurocosmetics reshape skincare as 79% favour natural tags
A GlobalData survey showed rising interest in stress-linked skin solutions.
3 days ago
IHH, Fortis drive India’s health-tech startups towards deployment
Three-month programme moves startups beyond pilots.
6 days ago
Radiopharma market to hit $21.8b by 2033 on cancer therapy boom
The Asia-Pacific region is projected to have the highest growth rate.
6 days ago
Medical fibre optics to hit $1.5b by 2030 as minimally invasive surgery surges
The 6.2% CAGR reflects global growth in high-resolution diagnostic fibres and biomedical sensing.
Medical simulation market set to reach $7.23b by 2030
Forecast implies 15.6% annual growth.
Health sterotypes block early preventative actions amongst Asians: AIA
Rigid beliefs discourage early health action across Asia.
AI, chatbots cut nurse paperwork burdens
Hospitals are deploying barcoding and digital booking tools to relieve staffing strain.
SMART and NUS weaponize AI to give soft robots human-like reflexes
The system reduced tracking error by 44% to 55% under heavy disturbances.
$2.17b AI surge projected by 2034 amidst pursuit to end missed cancer diagnoses
Asia-Pacific drives the fastest growth.
China captures 49% of global drug deals in 2025 amidst lower costs, faster timelines
This is an improvement from only 6% in 2020.
Strong pipeline, M&A activity could trigger rapid earnings for Greater China's healthcare firms: UOB
The industry is expected to become a key international player.
India’s Bio Pharma Shakti scheme signals end of import reliance
The national initiative targets drug affordability and R&D expansion.